Junji Saruwatari

14PUBLICATIONS
56CO-AUTHORS
Molecular targetsGlycoconjugatesPharmacogenomicsBiologically active moleculesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 23, 2026
Sex-specific risk factors for genital infections associated with SGLT2 inhibitors in type 2 diabetes: a retrospective cohort study and disproportionality analysis using JADER.

|Jul 07, 2025
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study.

Ayami Kajiwara-Morita, Kentaro Oniki, Akira Yoshida

|May 13, 2025
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses.

Keiichi Shigetome, Tomoko Egashira, Tetsu Tomita

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Dec 11, 2024
Association Between ALDH2 Genotypes and Atrial Fibrillation Recurrence Following Catheter Ablation: Prospective Multicenter Cohort Study.

Tadashi Hoshiyama, Keiichi Ashikaga, Kenji Morihisa

|Dec 10, 2024
Drug-induced megacolon in schizophrenia: a pharmacovigilance study of antipsychotic medications from the Japanese Adverse Drug Event database: a disproportionality analysis.

Keita Tokumitsu, Norio Sugawara, Yuki Kondo

Pageof 3

Frequent Collaborators

6 joint publications

Kentaro Oniki

3 joint publications

Ayami Kajiwara-Morita

3 joint publications

Norio Yasui-Furukori

2 joint publications

Hiroshi Watanabe